MB, Levis & Associates’s Aflac AFL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.8K Buy
715
+4
+0.6% +$460 0.03% 92
2026
Q1
$78K Buy
711
+4
+0.6% +$443 0.03% 91
2025
Q4
$78K Buy
707
+4
+0.6% +$441 0.03% 92
2025
Q3
$78.5K Buy
703
+4
+0.6% +$420 0.03% 91
2025
Q2
$73.8K Buy
699
+4
+0.6% +$420 0.03% 105
2025
Q1
$77.3K Buy
695
+3
+0.4% +$318 0.04% 100
2024
Q4
$71.6K Buy
692
+3
+0.4% +$327 0.04% 103
2024
Q3
$77K Buy
689
+3
+0.4% +$305 0.04% 100
2024
Q2
$61.2K Buy
686
+4
+0.6% +$344 0.03% 106
2024
Q1
$58.5K Buy
682
+5
+0.7% +$410 0.03% 112
2023
Q4
$55.9K Buy
677
+3
+0.4% +$242 0.03% 109
2023
Q3
$51.7K Buy
674
+4
+0.6% +$297 0.03% 112
2023
Q2
$46.8K Buy
670
+4
+0.6% +$268 0.03% 117
2023
Q1
$43K Buy
666
+4
+0.6% +$274 0.03% 117
2022
Q4
$47.6K Buy
+662
New +$44.3K 0.04% 108

Other funds holding AFL

MB, Levis & Associates's AFL Position: Q2 2026 in Review

MB, Levis & Associates increased its Aflac (AFL) stake by 0.56% in Q2 2026, buying an estimated $460 and bringing the position to 715 shares worth $83.8K. The position accounts for 0.03% of the portfolio, ranked #92.

MB, Levis & Associates first reported a position in AFL in Q4 2022 and has held it in 15 quarters since. 523 funds tracked by Wall St. Rank hold AFL as of Q2 2026.

  • MB, Levis & Associates held 715 shares of Aflac worth $83.8K as of Q2 2026.
  • MB, Levis & Associates bought 4 Aflac shares in Q2 2026, an estimated $460.
  • Aflac made up 0.03% of MB, Levis & Associates's portfolio in Q2 2026, its #92 holding.
  • MB, Levis & Associates first reported a position in Aflac in Q4 2022 and has held it in 15 quarters since.
  • 523 funds tracked by Wall St. Rank held Aflac as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.